Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-03-23 | Alan Rubino has been a Vericel Board member since 2005, possessing a wealth of experience spanning nearly 40 years across a multitude of disciplines within the biotechnology and pharmaceutical industries. He recently served for seven years as CEO of Emisphere Technologies, Inc., a successful publicly-held drug delivery company, which was acquired by Novo Nordisk for $1.8B. The director compensation table reflects all compensation awarded to, earned by or paid to our non-employee directors for the fiscal year ended December 31, 2022. Alan Rubino received $75,000 in cash fees, $83,174 in stock awards, and $126,874 in option awards, totaling $285,048. |
| 2024-03-21 | Alan Rubino, 69, Independent, Former Chief Executive Officer, Emisphere Technologies, Inc., Director Since: 2005, Vericel Board committee(s): Audit and Compensation (Chair) Committees, Director compensation total: $334,016 |
| 2025-03-20 | Alan Rubino, 70 Independent Former Chief Executive Officer, Emisphere Technologies, Inc. Director Since: 2005 Vericel Board committee(s): Audit and Compensation (Chair) Committees Director compensation table: Total $447,398 |
Data sourced from SEC filings. Last updated: 2026-02-03